Co-Authors
This is a "connection" page, showing publications co-authored by Marissa Howard-McNatt and Edward Levine.
Connection Strength
2.321
-
Howard-McNatt M, Schroll RW, Hurt GJ, Levine EA. Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations. Am J Surg. 2011 Sep; 202(3):298-302.
Score: 0.398
-
Howard-McNatt M, Geisinger KR, Stewart JH, Shen P, Levine EA. Is intraoperative imprint cytology evaluation still feasible for the evaluation of sentinel lymph nodes for lobular carcinoma of the breast? Ann Surg Oncol. 2012 Mar; 19(3):929-34.
Score: 0.398
-
Howard-McNatt M, Dupont E, Tsangaris T, Garcia-Cantu C, Chiba A, Berger AC, Levine EA, Gass JS, Ollila DW, Chagpar AB. Impact of Cavity Shave Margins on Margin Status in Patients with Pure Ductal Carcinoma In Situ. J Am Coll Surg. 2021 Apr; 232(4):373-378.
Score: 0.189
-
Miller-Ocuin JL, Fowler BB, Coldren DL, Chiba A, Levine EA, Howard-McNatt M. Is Excisional Biopsy Needed for Pure FEA Diagnosed on a Core Biopsy? Am Surg. 2020 Sep; 86(9):1088-1090.
Score: 0.185
-
Merrill AY, Garland MM, Howard-McNatt M, Isnassuos M, Perry KC, Levine EA. What Is the Utility of Routine Complete Blood Count, Liver Function Tests, and Chest X-ray in the Evaluation of Patients with Clinically Node-Negative Breast Cancer? Am Surg. 2019 Jan 01; 85(1):29-33.
Score: 0.165
-
Merrill AY, Brown DR, Klepin HD, Levine EA, Howard-Mcnatt M. Outcomes after Mastectomy and Lumpectomy in Octogenarians and Nonagenarians with Early-Stage Breast Cancer. Am Surg. 2017 Aug 01; 83(8):887-894.
Score: 0.150
-
Allen S, Levine EA, Lesko N, Howard-Mcnatt M. Is Excisional Biopsy and Chemoprevention Warranted in Patients With Atypical Lobular Hyperplasia on Core Biopsy? Am Surg. 2015 Sep; 81(9):876-8.
Score: 0.131
-
Ahmed S, Lawrence J, Stewart JH, Melin S, Levine EA, Howard-McNatt M. Does age predict outcome in patients with inflammatory breast cancer? Am Surg. 2014 Aug; 80(8):E221-4.
Score: 0.122
-
Howard-McNatt M, Lawrence J, Melin SA, Levine EA, Shen P, Stewart JH. Race and recurrence in women who undergo neoadjuvant chemotherapy for breast cancer. Am J Surg. 2013 Apr; 205(4):397-401.
Score: 0.110
-
Howard-McNatt M, Forsberg C, Levine EA, DeFranzo A, Marks M, David L. Breast cancer reconstruction in the elderly. Am Surg. 2011 Dec; 77(12):1640-3.
Score: 0.101
-
Beard HR, Cantrell EF, Russell GB, Howard-McNatt M, Shen P, Levine EA. Outcome after mastectomy for ipsilateral breast tumor recurrence after breast conserving surgery. Am Surg. 2010 Aug; 76(8):829-34.
Score: 0.092
-
Kaminski JP, Case D, Howard-McNatt M, Geisinger KR, Levine EA. Sentinel lymph node intraoperative imprint cytology in patients with breast cancer-costly or cost effective? Ann Surg Oncol. 2010 Nov; 17(11):2920-5.
Score: 0.092
-
Dupont E, Tsangaris T, Garcia-Cantu C, Howard-McNatt M, Chiba A, Berger AC, Levine EA, Gass JS, Gallagher K, Lum SS, Martinez RD, Willis AI, Pandya SV, Brown EA, Fenton A, Mendiola A, Murray M, Solomon NL, Senthil M, Ollila DW, Edmonson D, Lazar M, Namm JP, Li F, Butler M, McGowan NE, Herrera ME, Avitan YP, Yoder B, Walters LL, McPartland T, Chagpar AB. Resection of Cavity Shave Margins in Stage 0-III Breast Cancer Patients Undergoing Breast Conserving Surgery: A Prospective Multicenter Randomized Controlled Trial. Ann Surg. 2021 05 01; 273(5):876-881.
Score: 0.049
-
Chagpar AB, Garcia-Cantu C, Howard-McNatt MM, Gass JS, Levine EA, Chiba A, Lum S, Martinez R, Brown E, Dupont E. Does Localization Technique Matter for Non-palpable Breast Cancers? Am Surg. 2021 Apr 15; 31348211011135.
Score: 0.048
-
Miller-Ocuin JL, Howard-McNatt M, Levine EA, Chiba A. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy? Am Surg. 2020 Aug; 86(8):955-957.
Score: 0.046
-
Chiba A, Bawaneh A, Velazquez C, Clear KYJ, Wilson AS, Howard-McNatt M, Levine EA, Levi-Polyachenko N, Yates-Alston SA, Diggle SP, Soto-Pantoja DR, Cook KL. Neoadjuvant Chemotherapy Shifts Breast Tumor Microbiota Populations to Regulate Drug Responsiveness and the Development of Metastasis. Mol Cancer Res. 2020 01; 18(1):130-139.
Score: 0.044